Work

Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.3_suppl.401

Authors: Abby B. Siegel, Anthony B. El-Khoueiry, Richard S. Finn, Katherine Guthrie, Alan P. Venook, Charles David Blanke, Robert S. Brown

Institutions: Columbia University, USC Norris Comprehensive Cancer Center, University of California, Los Angeles, Fred Hutch Cancer Center, University of California, San Francisco, Oregon Health & Science University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4245226708

Cites:

Cited by: 2

Related to: 10